Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56305
Title: Imatinib might constitute a treatment option for lung involvement in COVID-19.
Authors: 
Mesh: 
Issue Date: 3-May-2020
Citation: Autoimmun Rev.2020;(19)7:102565
PMID: 32376403
URI: https://hdl.handle.net/20.500.12530/56305
Rights: openAccess
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
File SizeFormat 
PMC7252139.pdf236.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.